Colorectal Cancer Therapeutics Market Size will grow at a CAGR of 7.6% During 2021-2027 with Size, Share, Types, Products, Trends, Growth
Major Colorectal Cancer Therapeutics manufacturers are studied in this report for better understanding of global market scenario:
Merck Sharp & Dohme Corp.
Bristol Myers Squibb
Ipsen Biopharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
Taiho Pharmaceutical (Otsuka Pharmaceutical Co., Ltd.)
Teva Pharmaceutical Industries Ltd.
Eli Lilly and Company
Get Sample Report Brochure Of Colorectal Cancer Therapeutics Market at:
The global colorectal cancer therapeutics market size is projected to reach USD 16.58 billion by 2026, owing to the rise in the prevalence of colorectal cancer worldwide. A report by Fortune Business Insights™ titled, “Colorectal Cancer Therapeutics Market Size, Share & Industry Analysis, By Therapy (Targeted Therapy, Immunotherapy, Chemotherapy, Others), By Cancer Type (Colorectal Adenocarcinoma, Gastrointestinal Carcinoid Tumors, Others), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and Regional Forecast, 2019-2026,” provides a detailed analysis of the same.
According to the report, the colorectal cancer drugs market was valued at USD 9.26 billion in 2018. The forecast period is set from 2019 to 2026, and the market is likely to exhibit a CAGR of 7.6%. As per current colorectal cancer therapeutics market trends, the targeted therapy segment is dominating the market in terms of therapy. This is attributed to the presence of a large number of prominent targeted cancer therapies such as Stivarga, Erbitux, and Avastin.
The global pandemic, COVID-19, has led to severe repercussion owing to its widespread effects across several economies. Several industries are facing unprecedented losses owing to the lockdown announced by several governments across the globe that has resulted in the complete shutdown of the businesses. The crippling economy, however, is being revived through collective efforts from the government as well as the industries and is expected to bounce back in the coming years.
Speak to Colorectal Cancer Therapeutics Industry Analyst:
Key questions answered in the report:
What are the opportunities & challenges for new entrants?
Who are the prominent vendors present in the global market?
Which segment would provide the most opportunity for market growth?
Where will the current developments take the industry in the long term?
Fortune Business Insights Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune -411045, Maharashtra, India.
US: +1 424 253 0390
UK: +44 2071 939123
APAC: +91 744 740 1245
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Colorectal Cancer Therapeutics Market Size will grow at a CAGR of 7.6% During 2021-2027 with Size, Share, Types, Products, Trends, Growth here
News-ID: 2369019 • Views: 251
More Releases from Fortune Business Insights
Mobility Scooter Market 2021 by Manufacturers, Regions, Type and Application, Fo …
The global mobility scooters market size is expected to gain momentum by reaching USD 1.85 billion while exhibiting a CAGR of 6.9% between 2020 and 2027. This is attributable to the growing focus on developing innovative mobility scooters and the increasing prevalence of neurological disorders across the globe. This information is published by Fortune Business Insights, in its latest report, titled, “Mobility Scooters Market Size, Share & Industry Analysis, By
Surgical Stapling Devices Market Trending Technologies, Development Plans and Fu …
The rising prevalence of chronic diseases is expected to contribute positively to the surgical stapling devices market, says Fortune Business Insights in a report, titled “Surgical Stapling Devices Market Size, Share & Industry Analysis, By Product Type (Powered, Manual), By Type (Disposable, Re-usable), By Application (Gynecology Surgery, Urology Surgery, General Surgery, Others), By Surgery Type (Open Surgery, Laparoscopic Surgery), By End-user (Hospitals, Speciality Clinics, Others) and Regional Forecast, 2019-2026.” The
DNA Sequencing Market | Dynamics, Market Size, Analysis, Development, Revenue, F …
The Global DNA Sequencing Market size is expected to gain momentum backed by the increasing incidence of suicides and the growing number of psychiatrists that is likely to boost the adoption of advanced DNA Sequencing modules worldwide. This information is published by Fortune Business Insights in its upcoming report, titled, ““DNA Sequencing Market Size, Share & Industry Analysis, By Type (Instruments, Reagents & Consumables, Workflow Products, Services), By Technology (Next
Radiofrequency Ablation Systems Market 2021 Global Industry Size Forecast 2027
The increasing prevalence of cancer and rising demand for treating such chronic diseases are propelling the Global Radiofrequency Ablation Systems Market, finds Fortune Business Insights in their recent study. The study is titled, “Radiofrequency Ablation Systems Market: Global Market Analysis, Insights, and Forecasts, 2020 – 2027.” The market, as per study, will exhibit growth at a promising CAGR on account of rising prevalence of both cardiovascular and chronic diseases around the
More Releases for Colorectal
Colorectal Cancer Drug Development Pipeline Review, 2017
ReportsWorldwide has announced the addition of a new report title Colorectal Cancer Drug Development Pipeline Review, 2017 to its growing collection of premium market research reports. Summary This report provides an overview of the colorectal cancer pipeline landscape. The report provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for anal, rectal and colorectal cancer, and features dormant and discontinued projects. Anal cancer starts in the anus.
Colorectal Cancer Pipeline Therapeutic Review H1 2017
Colorectal Cancer Pipeline Review H1 2017 provides an overview of the Colorectal Cancer (Oncology) pipeline landscape. Colorectal cancer is cancer that starts in the large intestine (Colorectal). There is no single cause of colorectal cancer. Nearly all colorectal cancers begin as noncancerous (benign) polyps, which slowly develop into cancer. For More on Colorectal Cancer Pipeline Review H1 2017 Report Inquire @ https://goo.gl/1HQ4Fn . Report Description: Pharmaceutical guide Colorectal Cancer - Pipeline Review H1
US Colorectal Cancer Drug Pipeline Analysis
Among all the regions affected with colorectal cancer, the US would continue to account for a giant’s share owing to its huge population base. With regards to rates of increase, it is most likely that the US would witness a modest increase in the prevalence of the disease, mostly as a result of the country having already reached epidemic proportions of the disease. According to estimates, approximately 55,000 people die
Colorectal Cancer - Market Insights, Epidemiology, Growth and Forecast 2017-2023
Market Research HUB's report "Colorectal cancer - Market Insights, Epidemiology and Market Forecast-2023" provides an overview of the disease and global market size of the Colorectal Cancer (CRC) for the United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. It also includes global historical and forecasted epidemiological data for the diagnosed cases of Colorectal Cancer (CRC) from 2013-2023. According to DelveInsight, the 7MM Diagnosed cases for Colorectal Cancer are
Colorectal Cancer - Heat Map and Analysis
ReportsWorldwide has announced the addition of a new report title Colorectal Cancer - Heat Map and Analysis to its growing collection of premium market research reports. Colorectal cancer (CRC), otherwise known as bowel cancer, is a malignancy originating in the colon (the large intestine) or rectum, both of which are located towards the end of the human gastrointestinal tract. It begins as a benign tumor, which is almost always in
Colorectal Cancer Treatment Market- Global Outlook 2024
Colorectal cancer is cancer that starts in the colon or rectum. The colon and the rectum are parts of the large intestine, which is the lower part of the body’s digestive system. The colon absorbs water and nutrients from the food and stores waste matter (stool). Stool moves from the colon into the rectum before it leaves the body. Colorectal cancer often begins as a growth called a polyp, which